| Current Price | $1.51 | Mkt Cap | $262.2M |
|---|---|---|---|
| Open | $1.42 | P/E Ratio | -5.84 |
| Prev. Close | $1.51 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.41 - $1.58 | Volume | 2,539,792 |
| 52-Wk Range | $0.64 - $2.04 | Avg. Daily Vol. | 3,078,726 |
The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.
| Current Price | $1.51 | Mkt Cap | $262.2M |
|---|---|---|---|
| Open | $1.42 | P/E Ratio | -5.84 |
| Prev. Close | $1.51 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.41 - $1.58 | Volume | 2,539,792 |
| 52-Wk Range | $0.64 - $2.04 | Avg. Daily Vol. | 3,078,726 |
The best Bull and Bear pitches based on recency and number of recommendations.
Obviously this puts them in a tough spot with Fostamatinib but they do have a few bullets left to fire in 2013 along with some cash that was raised at the end of 2012. I think the offering priced at 9.50. Not saying I have much of a valuation model… More
I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!
Read the most recent pitches from players about RIGL.
Recs
Bigsef77
(51.82)
Submitted: 7/14/2020 5:45:53 PM :
Start Price:
$2.56
NASDAQ:RIGL Score:
-120.64
COVID trials
Recs
raspoutine
(< 20)
Submitted: 6/4/2019 3:41:48 PM :
Start Price:
$2.14
NASDAQ:RIGL Score:
-81.17
indication for their approved drug.
Recs
johnstrobel
(71.82)
Submitted: 9/26/2017 5:27:32 AM :
Start Price:
$2.39
NASDAQ:RIGL Score:
-108.06
https://www.fool.com/investing/2017/08/19/3-top-biotech-stocks-under-5.aspx?source=itxsitmot0000001&lidx=1
Find the members with the highest scoring picks in RIGL.
qubit15 (24.80) Score: +511.91
The Score Leader is the player with the highest score across all their picks in RIGL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| qubit15 | 24.80 | 1/21/2009 |
|
NS | $6.95 | -78.27% | +433.64% | +511.91 | 0 Comment | |
| robo2011 | 33.27 | 11/17/2008 |
|
NS | $6.53 | -76.88% | +407.26% | +484.14 | 0 Comment | |
| anticitradeshort | 26.97 | 4/20/2009 |
|
NS | $6.43 | -76.52% | +404.50% | +481.02 | 0 Comment | |
| cybob2000 | 44.70 | 10/23/2008 |
|
3W | $15.64 | -90.35% | +385.31% | +475.66 | 0 Comment | |
| schwah8 | 98.55 | 10/13/2008 |
|
NS | $18.26 | -91.73% | +363.82% | +455.55 | 0 Comment | |
| EV38biotech | < 20 | 11/5/2008 |
|
5Y | $8.60 | -82.44% | +345.29% | +427.74 | 0 Comment | |
| Mynx828 | 68.40 | 9/17/2009 |
|
5Y | $7.45 | -79.73% | +300.43% | +380.16 | 0 Comment | |
| longtermgrowth09 | 51.15 | 12/17/2009 |
|
5Y | $8.97 | -83.17% | +285.75% | +368.91 | 0 Comment | |
| darksider389 | 86.12 | 7/7/2008 |
|
3M | $21.97 | -93.13% | +253.96% | +347.09 | 0 Comment | |
| flats66 | 64.14 |
|
|
3Y | $22.71 | -93.35% | +244.63% | +337.98 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
